文献速递眼底病与葡萄膜炎青光眼角膜与眼表疾病

COVID-19 时代远程医疗中家庭视力测试的验证

Validation of Home Visual Acuity Tests for Telehealth in the COVID-19 Era.
PubMed 文献 · JAMA Ophthalmol · 2022-01-01

本研究在2020年7月至2021年4月从4个大学附属眼科诊所前瞻性随机纳入121例视力20/200或更好的参与者,比较3种家庭视力测试(印刷视力表、手机应用、网站)与诊所内最佳矫正Snellen视力。结果显示3种家庭测试与诊所内视力差异均在1行以内,但年龄较大者更可能受限使用数字工具。

要点

  • 3种家庭视力测试与诊所内视力差异均在1行以内。
  • 印刷视力表与诊所内视力的相关系数为0.72,手机应用为0.58,网站为0.64。
  • 年龄较大参与者更可能受限使用数字工具。

核心结论

  • 3种家庭视力测试(印刷视力表、手机应用、网站)的结果与诊所内视力测量在1行以内相当。
  • 年龄较大参与者更可能受限使用数字工具,随着远程眼科医疗扩展,需要进一步开发和验证家庭视力测试模式。

研究设计与样本

  • 2020年7月至2021年4月从4个大学附属眼科诊所(综合、角膜、青光眼和视网膜诊所)前瞻性随机纳入视力20/200或更好的符合条件的参与者。
  • 参与者被随机分配在标准眼科就诊前3天内自行完成3种家庭视力测试中的2种(印刷视力表、手机应用和网站),并完成评估家庭测试可用性的调查。
  • 就诊时以最佳矫正Snellen远视力作为参考标准。

主要发现

  • 共121例参与者完成研究,平均(SD)年龄63.8(13.0)岁。
  • 诊所内平均视力为0.11 logMAR(Snellen等效20/25),4个诊所参与者数量相似。
  • 家庭测试与诊所内视力的平均差值(logMAR):印刷视力表-0.07(95%CI,-0.10至-0.04),手机应用-0.12(95%CI,-0.15至-0.09),网站测试-0.13(95%CI,-0.16至-0.10)。
  • Pearson相关系数:印刷视力表0.72(95%CI,0.62-0.79),手机应用0.58(95%CI,0.46-0.69),网站测试0.64(95%CI,0.53-0.73)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 年龄较大参与者更可能受限使用数字工具。
  • 需要进一步开发和验证家庭视力测试模式,以配合远程眼科医疗的扩展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Visual acuity (VA) is one of the most important clinical data points in ophthalmology. However, few options for validated at-home VA assessments are currently available. OBJECTIVE: To validate 3 at-home visual acuity tests in comparison with in-office visual acuity. DESIGN, SETTING, AND PARTICIPANTS: Between July 2020 and April 2021, eligible participants with VA of 20/200 or better were recruited from 4 university-based ophthalmology clinics (comprehensive, cornea, glaucoma, and retina clinics). Participants were prospectively randomized to self-administer 2 of 3 at-home VA tests (printed chart, mobile phone app, and website) within 3 days before their standard-of-care clinic visit. Participants completed a survey assessing usability of the at-home tests. At the clinic visit, best-corrected Snellen distance acuity was measured as the reference standard. MAIN OUTCOMES AND MEASURES: The at-home VA test results were compared with the in-office VA test results using paired and unpaired t tests, Pearson correlation coefficients, analysis of variance, χ2 tests, and Cohen κ agreement. The sensitivity, specificity, positive predictive value, and negative predictive value of each at-home test were calculated to detect significant VA changes (≥0.2 logMAR) from the in-office baseline. RESULTS: A total of 121 participants with a mean (SD) age of 63.8 (13.0) years completed the study. The mean in-office VA was 0.11 logMAR (Snellen equivalent 20/25) with similar numbers of participants from the 4 clinics. Mean difference (logMAR) between the at-home test and in-office acuity was -0.07 (95% CI, -0.10 to -0.04) for the printed chart, -0.12 (95% CI, -0.15 to -0.09) for the mobile phone app, and -0.13 (95% CI, -0.16 to -0.10) for the website test. The Pearson correlation coefficient for the printed chart was 0.72 (95% CI, 0.62-0.79), mobile phone app was 0.58 (95% CI, 0.46-0.69), and website test was 0.64 (95% CI, 0.53-0.73). CONCLUSIONS AND RELEVANCE: The 3 at-home VA test results (printed chart, mobile phone app, and website) appeared comparable within 1 line to in-office VA measurements. Older participants were more likely to have limited access to digital tools. Further development and validation of at-home VA testing modalities is needed with the expansion of teleophthalmology care.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Bellsmith KN, Gale MJ, Yang S, et al. Validation of Home Visual Acuity Tests for Telehealth in the COVID-19 Era. JAMA Ophthalmol. 2022. PMID: 35357405. doi:10.1001/jamaophthalmol.2022.0396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。